ADHD Treatment Plan for Adults With Co-Occurring PTSD
This paper presents an individualized treatment plan for a 30-year-old female client diagnosed with ADHD alongside co-occurring PTSD, poly-substance abuse, and schizoaffective bipolar-type disorder. Drawing on clinical interview strategies, validated adult self-rating scales, and FDA-approved pharmacological options, the paper outlines key questions for the client and collateral informants, recommends appropriate diagnostic and physical tests, identifies differential diagnoses, and proposes a stimulant-based medication regimen. The analysis emphasizes the overlap between ADHD and PTSD symptomatology and the importance of comprehensive, multi-source assessment to improve diagnostic accuracy and guide effective treatment in adults.
- Introduction: Client profile and paper purpose
- Questions to Ask the Client: Clinical interview questions for client and collaterals
- Diagnostic and Physical Tests: Rating scales and structured diagnostic tools
- Differential Diagnoses for the Client: PTSD, depression, and mood disorder compared
- Treatment: FDA-approved stimulant regimens and dosages
- Conclusion: Diagnostic complexity and clinical takeaways
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds clinical recommendations in specific, named diagnostic tools (Wender-Utah Rating Scale, Adult ADHD Self-Report Scale, DSM-V structured interview), giving the treatment plan concrete procedural authority.
- Systematically addresses multiple stakeholder perspectives — client, spouse, professors, and colleagues — to build a holistic picture of symptom expression across settings.
- Compares two FDA-approved stimulant classes (methylphenidate vs. amphetamine) with explicit pharmacological rationale tied to the client's cardiovascular risk profile, demonstrating evidence-based clinical reasoning.
Key academic technique demonstrated
The paper uses differential diagnosis reasoning to distinguish ADHD from PTSD and mood disorders by systematically mapping shared and unique symptoms. This technique — acknowledging diagnostic overlap while identifying the most parsimonious diagnosis — is central to graduate-level clinical case writing and reflects the DSM-5's polythetic approach to psychiatric classification.
Structure breakdown
The paper follows a clinical case-study format in six sections: an introduction establishing the client's presenting profile; a section on interview questions for the client and collateral informants; a review of recommended physical and diagnostic tests; a differential diagnosis analysis; a pharmacological treatment plan with dosage specifics; and a brief conclusion synthesizing key takeaways about ADHD diagnosis in adulthood.
Introduction
Attention Deficit Hyperactivity Disorder (ADHD) affects clients across the lifespan, although it is more common in children. Data from the Centers for Disease Control and Prevention (CDC) indicates that approximately 6.1 million children in the US had ADHD in 2016 (CDC, 2019). In some cases, however, ADHD is not detected early and progresses into adulthood, where it affects an individual's ability to run a household, maintain employment, and care for children. The presenting client is a 30-year-old female diagnosed with post-traumatic stress disorder (PTSD), poly-substance abuse, and long-standing schizoaffective bipolar-type disorder. The client reports involvement in criminal activity, impulsiveness, hallucinations, difficulty managing anger, persecutory ideation, poor academic performance, and self-mutilatory behavior. This paper seeks to develop an individualized treatment plan for the client with co-occurring ADHD and PTSD.
Questions to Ask the Client
Clinical interviews are crucial for effective treatment. A fundamental question to ask the client is whether they have a history of vocal and motor tics. Tics are a symptom of Tourette Syndrome, which is prevalent among ADHD patients (Kolar et al., 2008). The FDA approves stimulants as first-line treatments for adults with ADHD. However, stimulants are associated with a risk of exacerbating tics in clients with tic disorders (Kolar et al., 2008). Identifying whether Tourette Syndrome exists would help the PMHNP determine the appropriate dosage of stimulants to prescribe in order to minimize the risk of tics. It would also be crucial to ask whether the client has a history of cardiovascular problems. Stimulants have been associated with a heightened risk of cardiovascular disease in patients with ADHD, and the PMHNP may need to decide whether or not to prescribe stimulants for the client (Dalsgaard, 2014). Lower doses of FDA-approved non-stimulants may be a better option for clients with an elevated potential for cardiovascular disease (Dalsgaard, 2014). Finally, there is a need to ask the client what their specific treatment targets are. Identifying what the client expects to gain from treatment is a crucial factor in determining the most relevant treatment plan.
Apart from the client, the PMHNP also needs to conduct interviews with other parties who closely interact with the presenting client in order to further assess her situation. For the presenting client, the PMHNP could obtain feedback from her spouse, her professor, and colleagues at work. Specific questions could include: What types of behavior impair the client's learning? In what circumstances is the client disruptive, and when is she not disruptive? In what types of activities does the client appear most focused, and when is she not focused at all? These questions would provide insight into the specific activities that trigger certain behaviors, such as disruptiveness and self-mutilatory tendencies. Cognitive-behavioral therapy could then focus on helping the client manage negative behaviors that contribute to disruptive tendencies. Furthermore, identifying the specific activities that keep the client focused could form a basis for educating family members, professors, and colleagues on how to engage her in ways that promote concentration. Finally, understanding when the client is most disruptive would help the PMHNP advise relevant parties on how to recognize at-risk situations and implement strategies to minimize the occurrence of negative behaviors.
Diagnostic and Physical Tests
Physical tests conducted on the client could include checking for hearing impairment, visual impairment, malnutrition, and evidence of abuse (Smucker & Hedayat, 2001). However, these physical tests need to be complemented with diagnostic tests approved for use with adult patients. Self-rating scales recommended for adults such as the presenting client include the Wender-Utah Rating Scale for ADHD and the Adult ADHD Self-Report Scale. The Wender-Utah Rating Scale is a 25-item scale that assesses ADHD in adults based on childhood symptoms. Respondents are asked to specify the extent to which they agree with each of the 25 items on a scale of 0 to 4. ADHD is considered likely if the client reports a score of at least 46 points.
The Adult ADHD Self-Report Scale consists of the 18 DSM-IV-TR criteria for ADHD (ADDA, 2015). A positive screening result for ADHD is indicated if the client reports a score of at least four points on the six-item Part A of the scale, which measures how often a client feels compelled or overly driven to do things, squirms or fidgets, delays getting started on tasks requiring significant thought, and how often they have trouble wrapping up the final details of a project, getting things in order, and remembering appointments (ADDA, 2015). The results obtained from these screening tests could inform a more in-depth clinical interview — such as the DSM-5 structured interview — to provide an accurate ADHD diagnosis. The DSM-5 criteria diagnose ADHD by assessing symptoms or behaviors that have persisted for at least six months across at least two distinct settings, such as school, work, and home. For an adult client to receive a positive ADHD diagnosis, they must demonstrate at least five of the diagnostic symptoms and/or behaviors.
Conclusion
The FDA approves stimulants and non-stimulants for the treatment of ADHD in adults. However, most ADHD cases are diagnosed in childhood, with diagnoses in adulthood often complicated by symptom overlap with other common disorders. For instance, adults with PTSD present with symptoms similar to those of ADHD patients, underscoring the need for clinicians to administer multiple diagnostic tests as a means of improving diagnostic accuracy and developing effective, individualized treatment plans.
References
APA (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (5th ed.). Washington, DC: American Psychiatric Association.
ADDA (2015). Adult ADHD Self-Report Scale: Symptom Checklist Instructions. Attention Deficit Disorder Association. Retrieved from https://add.org/wp-content/uploads/2015/03/adhd-questionnaire-ASRS111.pdf
CDC (2019). Data and Statistics about ADHD. Centers for Disease Control and Prevention. Retrieved from
CMS (2016). Stimulant and Related Medications: US Food and Drug Administration – Approved Indications and Dosages for Use in Adults. Center for Medicare and Medicaid Services. Retrieved from
Dalsgaard, S., Kvist, A., Leckman, F. J., Nielsen, H., & Simonsen, M. (2014). Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: A nationwide prospective cohort study. Journal of Child and Adolescent Psychopharmacology, 24(6), 302–310.
Kolar, D., Keller, A., Golfinopoulos, M., Cumyn, L., Syer, C., & Hechtman, L. (2008). Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 4(2), 389–403.
Smucker, W., & Hedayat, M. (2001). Evaluation and treatment of ADHD. American Family Physician, 64(5), 817–830.
Create your account
Always verify citation format against your institution’s current style guide requirements.